AvinaK(Kapoor)SinghMD

PubMed

• 103 citations
  Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
  Tait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, Elisabeth M Paietta, Susan O'Brien, Jacqueline Barrientos, Diane F Jelinek, Esteban Braggio, Jose F Leis, Cong Ch...> ;Blood. 2022 Jul 14
• 22 citations
  Measurable Residual Disease Does Not Preclude Prolonged Progression-free Survival in CLL Treated with Ibrutinib.
  Victoria Wang, Curtis A. Hanson, Renee C. Tschumper, Connie Lesnick, Esteban Braggio, Elisabeth Paietta, Susan O'Brien, Jacqueline C. Barrientos, Jose F. Leis, Cong Ch...> ;Blood. 2021 Aug 18
• 122 citations
  Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autolog...
  Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina K. Singh, Terri L. Parker, Alexander R. Menter, Xuezhong Yang, Benjamin M. Par...> ;The Lancet. Oncology. 2020 Oct 1
• 442 citations
  Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
  Tait D. Shanafelt, Xin V. Wang, Neil E. Kay, Curtis A. Hanson, Susan O'Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, Jose F. Leis, Cong C. Zhang,...> ;The New England Journal of Medicine. 2019 Jul 31
• Basion–Cartilaginous Dens Interval: An Imaging Parameter for Craniovertebral Junction Assessment in Children
  R Tiwari, B Tantiwongkosi, L Lu, W B Altmeyer, X Zhang, A K Singh, Z Fulton> ;American Journal of Neuroradiology. 2017 Oct 07
• Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Co-Morbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Unde...
  S Ganguly, J McGuirk, A K Singh, S Abhyankar, L Shune> ;Biology of Blood and Marrow Transplantation. 2017 Jun 13
• 6 citations
  Prognostic factors for breast cancer and their use in the clinical setting.
  Avina Kapoor, Victor G. Vogel> ;Expert Review of Anticancer Therapy. 2005 Apr 1
• Join now to see all

Abstracts/Posters

• Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E19...
  Avina Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019